CenterBook Partners’s GeneDx Holdings WGS Stock Holding History

CenterBook Partners’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,893	Closed	-$2.33M	–	792
2025 Q4	$2.33M	Buy	+17,893	New	+$2.46M	0.11%	243

Other funds holding WGS

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ZDA

Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CenterBook Partners's WGS Position: Q1 2026 in Review

CenterBook Partners sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 17,893 shares — an estimated $2.33M sold.

CenterBook Partners first reported a position in WGS in Q4 2025 and held it in 1 quarter. The position peaked at $2.33M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

CenterBook Partners reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
CenterBook Partners sold 17,893 GeneDx Holdings shares in Q1 2026, an estimated $2.33M.
CenterBook Partners first reported a position in GeneDx Holdings in Q4 2025 and held it in 1 quarter.
CenterBook Partners's GeneDx Holdings position peaked at $2.33M in Q4 2025.
240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on CenterBook Partners's 13F filing for Q1 2026, filed 5 May 2026.